Pharmacoeconomic Considerations in Assessing and Selecting Congestive Heart Failure Therapies

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.20, Iss.14, 2002-01, pp. : 963-977

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Perindopril: In Congestive Heart Failure

By Simpson D. Noble S. Goa K.L.

Drugs, Vol. 62, Iss. 9, 2002-01 ,pp. : 1367-1377

Adis International

Access to resources Recommend Favorite

Bisoprolol for congestive heart failure

By Rosenberg Jens Gustafsson Finn

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 293-300

Informa Healthcare

Access to resources Recommend Favorite

Nesiritide for the treatment of congestive heart failure

By Iyengar Srinivas Feldman David S Trupp Robin Abraham William T

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 901-907

Informa Healthcare

Access to resources Recommend Favorite

Role of endothelins in congestive heart failure

By Moe Gordon W Rouleau Jean L Nguyen Quang T Cernacek Peter Stewart Duncan J

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 6, 2003-06 ,pp. : 588-597

NRC Research Press

Access to resources Recommend Favorite

Emerging therapies for heart failure

By Rudolph Amy E McMahon Ellen G

Expert Opinion on Emerging Drugs, Vol. 7, Iss. 2, 2002-10 ,pp. : 247-258

Informa Healthcare

Access to resources Recommend Favorite